Evaluation of confirmatory data following the Article 12 MRL review for cyazofamid

The applicant ISK Biosciences Europe N.V. submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available. The data gap which was related to in...

詳細記述

保存先:
書誌詳細
出版年:EFSA J
主要な著者: Anastassiadou, Maria, Brancato, Alba, Brocca, Daniela, Carrasco Cabrera, Luis, De Lentdecker, Chloe, Erdos, Zoltan, Ferreira, Lucien, Greco, Luna, Jarrah, Samira, Kardassi, Dimitra, Leuschner, Renata, Lostia, Alfonso, Lythgo, Christopher, Medina, Paula, Miron, Ileana, Molnar, Tunde, Nave, Stefanie, Pedersen, Ragnor, Reich, Hermine, Sacchi, Angela, Santos, Miguel, Stanek, Alois, Sturma, Juergen, Tarazona, Jose, Theobald, Anne, Vagenende, Benedicte, Villamar‐Bouza, Laura
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
Reasoned Opinion
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7009532/
https://ncbi.nlm.nih.gov/pubmed/32625765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2018.5487
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料